Clinical Trials Browser

Phase 2 × Completed × Sulfasalazine × Clear all

NCT03847311 2025-01-09

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

Phase 2 Completed

7 enrolled 8 charts

Breast Neoplasms, Signs and Symptoms